March 27, 2008

For Press Inquiries:

Kelly O'Donnell
Director, Marketing and Communications
Beringea, LLC
kodonnell@beringea.com
(248) 489-9000

«Return to Newsroom

Investment Banking Team Expands
Director Michael Gross joins Beringea

Farmington Hills, Mich. — Beringea, an international private equity and investment banking firm, is pleased to announce the appointment of Michael Gross to Director of Investment Banking. Michael brings a broad range of transaction and valuation experience, including buy- and sell-side M&A advisory, capital raises, fairness opinions, and due diligence services. He specializes in serving clients within the healthcare and life sciences sectors, including medical devices, diagnostics, contract research organizations, hospitals and physician practices. Michael has authored numerous articles and research papers and frequently speaks to healthcare and manufacturing audiences on a variety of business topics.

Prior to joining Beringea, Michael was a vice president at P&M Corporate Finance (PMCF), a middle-market investment bank. While at PMCF, Michael led M&A transactions and capital raises for companies in the healthcare and life sciences sectors, among others. Before working at PMCF, Michael worked in the investment banking group at Stout Risius Ross, Inc.

Michael is a CFA charterholder and earned a BA in finance from Michigan State University.

About Beringea

Beringea LLC is an international private equity and investment banking firm with offices in Detroit, London, Los Angeles and Shanghai. Beringea advises corporate clients on issues related to mergers, acquisitions, divestitures, sell-side due diligence and corporate finance. Its team has experience serving clients in a variety of industries, including healthcare, media, transportation, and manufacturing. www.beringea.com